Track, trade, and explore $VITARNA and all frontier Science IP tokens here:
molecule.xyz/ipts/vitarn...

Latest updates:
> Manufacturer factory visit
> Early scoping underway for potential human trials

Every milestone, dataset, and research update streams through Molecule Labs and flows directly into VITARNA's token page.

Project lead @Mykalt45 found the same mutation pattern across proteins controlling:

> DNA repair
> Tumor suppression
> Epigenetic regulation

Under optimal conditions, $VITARNA could become a platform therapy –- one approach, many cures.

Nonsense mutations act like “stop signs” in our DNA, cutting proteins short and breaking vital cellular processes.

> Goal = Suppress deleterious codon mutations
> Outcome = Restore proper protein function

Track, trade, + explore $BeeARD and all other frontier Science IP Tokens on Molecule:
molecule.xyz/ipts/beeard...

Last week, the team premiered V2 of graph surfer -- a game that let's you learn about psychedelic science by surfing the knowledge graph.
twitter.com/BeeARDai/st...">November

The goal: compress the path from idea to hypothesis, to therapeutic candidate.

So far, BeeARD has generated 15+ testable hypotheses including:

> Psilocybin's effects on the default mode network and nicotine dependence.
> Psilocybin's potential influence on gait control in Parkinson's disease.

Track, trade, + explore frontier science IP Tokens on Molecule:
molecule.xyz/?utm_source...

And it's accelerating.

> @KristerKauppi just live launched a chemical partial reprogramming token together with @ReprogLab + @pumpdotscience. More longevity token launches are expected this week.

Now for the first time, longevity breakthroughs like these are onchain

> VITARNA - gene therapy for nonsense mutations in age-related diseases.
> VITAFAST - fast-tracking autophagy-boosting small molecules to rejuvenate aging cells and treat age-related conditions.

Both exploring potentia trials.

> The company is developing a cellular reprogramming treatment that, if successful, could treat a wide range of age-related diseases.

> They’ll use partial epigenetic reprogramming, a method to turn back a cell’s biological clock.

Source: observer.com/2025/10/thi...

Track, trade, + explore Aubrai and all other frontier Science IP Tokens here:
molecule.xyz/ipts/aubrai...

Working on something where an AI co-scientist helps?

Share your research field, goal, + constraint
> What should Aubrai tackle first?

All new BioAgents launching on @BioProtocol
can be tokenized into fundable research assets on Molecule.

Aubrai's latest hypothesis aims to reset inflammaging, a persistent, low-grade inflammation that accelerates aging.

> Projected outcome in aged mice: +25% median lifespan and a significant reduction in markers like IL-6.

Latest integration with x402 expands on this autonomous economy for science, enabling:

> Agent-to-agent micropayments
> Onchain agentic commerce across research and health use-cases.
twitter.com/vitadao/sta...">October

@Aubrai co-designed $VitaSTEM from 850k human single-cell profiles.

> The project aims to develop a therapeutic method to rejuvinate stem cells without transplantation.

> 20% of initial supply is owned by the agent itself.

Explore, track, + trade Molecule IP tokens here:
molecule.xyz/?utm_source...

With Molecule:

> Research IP becomes tokenized, liquid, and publicly trackable
> Progress updates are visible onchain via Molecule Labs
> MIRA, our native AI co-pilot, helps you navigate it all